The Health Factor AFRICA
Outbreak WatchDRC’s Ebola Outbreak Just Passed 6,700 Cases. Nearly Half of Everyone Infected Has Died.

Outbreak Watch

DRC’s Ebola Death Toll Just Passed 3,000. WHO Just Ruled Out the Vaccine Everyone Was Counting On.

Africa CDC says the outbreak remains "extremely serious" as it spreads across an area the size of the UK. The same week, WHO's own experts said the leading Ebola vaccine can't yet be used outside a research trial for this specific strain.

We’ve followed this outbreak from a river boat scare near Kinshasa, through its 100-day mark. This week brought two updates worth holding together: the death toll crossed a grim new threshold, and a vaccine many were counting on just got a harder ruling than expected.

Africa CDC confirmed the outbreak has now killed 3,009 people from 6,206 confirmed cases since May, calling the situation “extremely serious” despite continuous response efforts. Director-General Jean Kaseya noted the outbreak has expanded from one province and two health zones at declaration to 60 health zones across six provinces, an area of roughly 240,000 square kilometres, comparable in size to the United Kingdom. “Despite the considerable efforts of the government and partners, we are not yet where we need to be,” Kaseya said. Nigeria’s Health Ministry reports 1,409 recoveries and 830 patients still in isolation or hospital care.

The same week, WHO issued new emergency guidance following an Extraordinary Meeting of its Strategic Advisory Group of Experts on Immunization: evidence remains insufficient to support general programmatic use of Ervebo, the licensed Ebola vaccine used successfully in past outbreaks, against this outbreak’s Bundibugyo virus strain. WHO’s recommendation is specific: Ervebo should only be used within a research protocol for now, not rolled out broadly, until that evidence exists. This is a notable clarification on where vaccine efforts actually stand, more cautious than earlier reporting on trial progress suggested.

What You Can Do

  • Don’t assume a vaccine solution is imminent. WHO’s own guidance confirms Ervebo isn’t cleared for general use against this strain yet, only research-protocol use.
  • Follow Africa CDC and WHO updates directly given how quickly both the outbreak’s scale and the response’s tools are still shifting.

This article is for general information on an active outbreak. For the latest guidance, consult WHO, Africa CDC, or your national health authority directly.

The Health Factor Africa

Get Outbreak Watch in your inbox

New outbreaks, new data, sent the moment we publish.

    Sources

    1. Anadolu Agency (2026): "Africa health body says Ebola in DR Congo remains extremely serious"

    This does not replace seeing a health worker. If you notice these signs, visit your nearest primary health centre or speak to a doctor or nurse. Any costs mentioned are general estimates and vary by facility and state.

    Share on WhatsApp